BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.820
-0.015 (-0.82%)
At close: Sep 17, 2025, 4:00 PM EDT
1.910
+0.090 (4.95%)
After-hours: Sep 17, 2025, 7:30 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $13.71 million as of September 17, 2025. Its market cap has decreased by -18.86% in one year.
Market Cap
13.71M
Enterprise Value
-3.48M
1-Year Change
-18.86%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $13.71M, a decrease of -73.63%. That is a compound annual growth rate of -23.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 13.80M | -61.13% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |